BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24330428)

  • 1. Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations.
    Youn A; Simon R
    BMC Bioinformatics; 2013 Dec; 14():363. PubMed ID: 24330428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of constrained cancer driver genes based on mutation timing.
    Sakoparnig T; Fried P; Beerenwinkel N
    PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
    Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
    Elife; 2021 Jan; 10():. PubMed ID: 33427197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
    Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
    Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do mutator mutations fuel tumorigenesis?
    Fox EJ; Prindle MJ; Loeb LA
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):353-61. PubMed ID: 23592419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations.
    Carter H; Chen S; Isik L; Tyekucheva S; Velculescu VE; Kinzler KW; Vogelstein B; Karchin R
    Cancer Res; 2009 Aug; 69(16):6660-7. PubMed ID: 19654296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of cancer driver mutations in protein kinases.
    Torkamani A; Schork NJ
    Cancer Res; 2008 Mar; 68(6):1675-82. PubMed ID: 18339846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the order of mutations during tumorigenesis from tumor genome sequencing data.
    Youn A; Simon R
    Bioinformatics; 2012 Jun; 28(12):1555-61. PubMed ID: 22492649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Analysis of Cancer-Associated DNA Polymerase ε Variants in
    Barbari SR; Kane DP; Moore EA; Shcherbakova PV
    G3 (Bethesda); 2018 Mar; 8(3):1019-1029. PubMed ID: 29352080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features.
    Buisson R; Langenbucher A; Bowen D; Kwan EE; Benes CH; Zou L; Lawrence MS
    Science; 2019 Jun; 364(6447):. PubMed ID: 31249028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of carcinogenesis: is the mutator phenotype inevitable?
    Beckman RA
    Semin Cancer Biol; 2010 Oct; 20(5):340-52. PubMed ID: 20934514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutator mutations enhance tumorigenic efficiency across fitness landscapes.
    Beckman RA
    PLoS One; 2009 Jun; 4(6):e5860. PubMed ID: 19517009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of accumulated alterations in driver and passenger genes on response to radiation therapy.
    Seo Y; Tamari K; Takahashi Y; Minami K; Isohashi F; Suzuki O; Sumida I; Ogawa K
    Br J Radiol; 2020 May; 93(1109):20190625. PubMed ID: 32031414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Damaging Effect of Passenger Mutations on Cancer Progression.
    McFarland CD; Yaglom JA; Wojtkowiak JW; Scott JG; Morse DL; Sherman MY; Mirny LA
    Cancer Res; 2017 Sep; 77(18):4763-4772. PubMed ID: 28536279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapting the engine to the fuel: mutator populations can reduce the mutational load by reorganizing their genome structure.
    Rutten JP; Hogeweg P; Beslon G
    BMC Evol Biol; 2019 Oct; 19(1):191. PubMed ID: 31627727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network.
    Wei PJ; Zhang D; Xia J; Zheng CH
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):467. PubMed ID: 28155630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel driver tumor suppressors through functional interrogation of putative passenger mutations in colorectal cancer.
    Zhang L; Komurov K; Wright WE; Shay JW
    Int J Cancer; 2013 Feb; 132(3):732-7. PubMed ID: 22753261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cancer driver genes based on nucleotide context.
    Dietlein F; Weghorn D; Taylor-Weiner A; Richters A; Reardon B; Liu D; Lander ES; Van Allen EM; Sunyaev SR
    Nat Genet; 2020 Feb; 52(2):208-218. PubMed ID: 32015527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
    Sun S; Thorson JA; Murray SS
    Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.